David J Seward

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Small Cell Lung Cancer

Monoclonal Antibody

Peritoneal Dialysis

Molecular Docking

Top Venues

Science advances

Cancer gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Reem Aboushousha, Jos L van der Velden, Nicholas Hamilton, Zhihua Peng, Maximilian B MacPherson, Cuixia Erickson, Sheryl White, Emiel F M Wouters, Niki L Reynaert, David J Seward, Jianing Li, Yvonne M W Janssen-Heininger
Glutaredoxin attenuates glutathione levels via deglutathionylation of Otub1 and subsequent destabilization of system x C . Science advances 9 (37) (2023)
Sean M Lenahan, Hailey M Sarausky, Paula Deming, David J Seward
STK11 loss leads to YAP1-mediated transcriptional activation in human KRAS-driven lung adenocarcinoma cell lines. Cancer gene therapy (2023)
Liam L Donnelly, Tyler C Hogan, Sean M Lenahan, Gopika Nandagopal, Jenna G Eaton, Meagan A Lebeau, Cai L McCann, Hailey M Sarausky, Kenneth J Hampel, Jordan D Armstrong, Margaret P Cameron, Nikoletta Sidiropoulos, Paula Deming, David J Seward
Functional assessment of somatic STK11 variants identified in primary human non-small cell lung cancers. Carcinogenesis (2021)